In Type 1 diabetes, the immune system mistakes the body’s healthy cells for foreign ones and tries to fight them. In this case, the immune system attacks and destroys the insulin-producing beta ...

A new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT) concluded that inhaled technosphere insulin ...

A novel islet cell therapy delivered through a single infusion lowered HbA1c and eliminated severe hypoglycemia events for ...

A study in the journal Diabetes Technology & Therapeutics (DTT) concludes that inhaled technosphere insulin (TI-Afrezza) ...

Type 1 diabetes represents an autoimmune condition where the body’s defense system mistakenly identifies insulin-producing beta cells as foreign invaders and systematically destroys them.

Technosphere insulin was tied to improvements in HbA1c for adults with type 1 diabetes. Proper dosing at mealtimes is essential for maximizing glycemic benefits with technosphere insulin.

type 1 diabetes (T1D) is an autoimmune condition. The body’s immune system attacks the beta cells that make insulin in the pancreas, meaning that organ can’t produce that hormone naturally any ...

Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...

Amsterdam played host to this year's edition of the International Conference on Advanced Technologies & Treatments for ...

Jaeb Center for Health Research conducted a randomized controlled trial evaluating the impact of automated insulin delivery ...